Industry: Chemical & Material
Published Date: 2025-01-19
Pages: 89 Pages
Report ld: 3526014
Request Sample
Customized Report
Glycerophosphorylcholine (GPC) Market Size(US$)

CAGR 2025-2031
5.7%
Market Size,2031
USD 105
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Glycerophosphorylcholine (GPC) was valued at US$ 72 million in the year 2024 and is projected to reach a revised size of US$ 105 million by 2031, growing at a CAGR of 5.7% during the forecast period.
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer"s disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Global key players of Glycerophosphorylcholine (GPC) include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co and Suzhou Fushilai Pharmaceutical, etc. Global top four manufacturers hold a share over 50%. China is the largest producer of Glycerophosphorylcholine (GPC), followed by Europe.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Glycerophosphorylcholine (GPC), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycerophosphorylcholine (GPC).
The Glycerophosphorylcholine (GPC) market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glycerophosphorylcholine (GPC) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glycerophosphorylcholine (GPC) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glycerophosphorylcholine (GPC) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Glycerophosphorylcholine (GPC) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Glycerophosphorylcholine (GPC) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Glycerophosphorylcholine (GPC) Market Overview
1.1 Product Definition
1.2 Glycerophosphorylcholine (GPC) by Type
1.2.1 Global Glycerophosphorylcholine (GPC) Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Liquid Glycerophosphorylcholine
1.2.3 Powder Glycerophosphorylcholine
1.3 Glycerophosphorylcholine (GPC) by Application
1.3.1 Global Glycerophosphorylcholine (GPC) Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Health Products
1.4 Global Market Growth Prospects
1.4.1 Global Glycerophosphorylcholine (GPC) Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Glycerophosphorylcholine (GPC) Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Glycerophosphorylcholine (GPC) Production Estimates and Forecasts (2020-2031)
1.4.4 Global Glycerophosphorylcholine (GPC) Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Glycerophosphorylcholine (GPC) Production Market Share by Manufacturers (2020-2025)
2.2 Global Glycerophosphorylcholine (GPC) Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Glycerophosphorylcholine (GPC), Industry Ranking, 2023 VS 2024
2.4 Global Glycerophosphorylcholine (GPC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Glycerophosphorylcholine (GPC) Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Glycerophosphorylcholine (GPC), Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Glycerophosphorylcholine (GPC), Product Offered and Application
2.8 Global Key Manufacturers of Glycerophosphorylcholine (GPC), Date of Enter into This Industry
2.9 Glycerophosphorylcholine (GPC) Market Competitive Situation and Trends
2.9.1 Glycerophosphorylcholine (GPC) Market Concentration Rate
2.9.2 Global 5 and 10 Largest Glycerophosphorylcholine (GPC) Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Glycerophosphorylcholine (GPC) Production by Region
3.1 Global Glycerophosphorylcholine (GPC) Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Glycerophosphorylcholine (GPC) Production Value by Region (2020-2031)
3.2.1 Global Glycerophosphorylcholine (GPC) Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Glycerophosphorylcholine (GPC) by Region (2026-2031)
3.3 Global Glycerophosphorylcholine (GPC) Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Glycerophosphorylcholine (GPC) Production Volume by Region (2020-2031)
3.4.1 Global Glycerophosphorylcholine (GPC) Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Glycerophosphorylcholine (GPC) by Region (2026-2031)
3.5 Global Glycerophosphorylcholine (GPC) Market Price Analysis by Region (2020-2025)
3.6 Global Glycerophosphorylcholine (GPC) Production and Value, Year-over-Year Growth
3.6.1 Europe Glycerophosphorylcholine (GPC) Production Value Estimates and Forecasts (2020-2031)
3.6.2 China Glycerophosphorylcholine (GPC) Production Value Estimates and Forecasts (2020-2031)
4 Glycerophosphorylcholine (GPC) Consumption by Region
4.1 Global Glycerophosphorylcholine (GPC) Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Glycerophosphorylcholine (GPC) Consumption by Region (2020-2031)
4.2.1 Global Glycerophosphorylcholine (GPC) Consumption by Region (2020-2025)
4.2.2 Global Glycerophosphorylcholine (GPC) Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Glycerophosphorylcholine (GPC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Glycerophosphorylcholine (GPC) Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Glycerophosphorylcholine (GPC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Glycerophosphorylcholine (GPC) Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Glycerophosphorylcholine (GPC) Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Glycerophosphorylcholine (GPC) Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Glycerophosphorylcholine (GPC) Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Glycerophosphorylcholine (GPC) Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Glycerophosphorylcholine (GPC) Production by Type (2020-2031)
5.1.1 Global Glycerophosphorylcholine (GPC) Production by Type (2020-2025)
5.1.2 Global Glycerophosphorylcholine (GPC) Production by Type (2026-2031)
5.1.3 Global Glycerophosphorylcholine (GPC) Production Market Share by Type (2020-2031)
5.2 Global Glycerophosphorylcholine (GPC) Production Value by Type (2020-2031)
5.2.1 Global Glycerophosphorylcholine (GPC) Production Value by Type (2020-2025)
5.2.2 Global Glycerophosphorylcholine (GPC) Production Value by Type (2026-2031)
5.2.3 Global Glycerophosphorylcholine (GPC) Production Value Market Share by Type (2020-2031)
5.3 Global Glycerophosphorylcholine (GPC) Price by Type (2020-2031)
6 Segment by Application
6.1 Global Glycerophosphorylcholine (GPC) Production by Application (2020-2031)
6.1.1 Global Glycerophosphorylcholine (GPC) Production by Application (2020-2025)
6.1.2 Global Glycerophosphorylcholine (GPC) Production by Application (2026-2031)
6.1.3 Global Glycerophosphorylcholine (GPC) Production Market Share by Application (2020-2031)
6.2 Global Glycerophosphorylcholine (GPC) Production Value by Application (2020-2031)
6.2.1 Global Glycerophosphorylcholine (GPC) Production Value by Application (2020-2025)
6.2.2 Global Glycerophosphorylcholine (GPC) Production Value by Application (2026-2031)
6.2.3 Global Glycerophosphorylcholine (GPC) Production Value Market Share by Application (2020-2031)
6.3 Global Glycerophosphorylcholine (GPC) Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Lipoid GmbH
7.1.1 Lipoid GmbH Glycerophosphorylcholine (GPC) Company Information
7.1.2 Lipoid GmbH Glycerophosphorylcholine (GPC) Product Portfolio
7.1.3 Lipoid GmbH Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Lipoid GmbH Main Business and Markets Served
7.1.5 Lipoid GmbH Recent Developments/Updates
7.2 Archimica SpA
7.2.1 Archimica SpA Glycerophosphorylcholine (GPC) Company Information
7.2.2 Archimica SpA Glycerophosphorylcholine (GPC) Product Portfolio
7.2.3 Archimica SpA Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Archimica SpA Main Business and Markets Served
7.2.5 Archimica SpA Recent Developments/Updates
7.3 Jiangsu Weiqida Pharmaceutical Co
7.3.1 Jiangsu Weiqida Pharmaceutical Co Glycerophosphorylcholine (GPC) Company Information
7.3.2 Jiangsu Weiqida Pharmaceutical Co Glycerophosphorylcholine (GPC) Product Portfolio
7.3.3 Jiangsu Weiqida Pharmaceutical Co Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Jiangsu Weiqida Pharmaceutical Co Main Business and Markets Served
7.3.5 Jiangsu Weiqida Pharmaceutical Co Recent Developments/Updates
7.4 Suzhou Fushilai Pharmaceutical
7.4.1 Suzhou Fushilai Pharmaceutical Glycerophosphorylcholine (GPC) Company Information
7.4.2 Suzhou Fushilai Pharmaceutical Glycerophosphorylcholine (GPC) Product Portfolio
7.4.3 Suzhou Fushilai Pharmaceutical Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Suzhou Fushilai Pharmaceutical Main Business and Markets Served
7.4.5 Suzhou Fushilai Pharmaceutical Recent Developments/Updates
7.5 Foman Biopharma
7.5.1 Foman Biopharma Glycerophosphorylcholine (GPC) Company Information
7.5.2 Foman Biopharma Glycerophosphorylcholine (GPC) Product Portfolio
7.5.3 Foman Biopharma Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Foman Biopharma Main Business and Markets Served
7.5.5 Foman Biopharma Recent Developments/Updates
7.6 JYOUKI Pharmaceutical Co
7.6.1 JYOUKI Pharmaceutical Co Glycerophosphorylcholine (GPC) Company Information
7.6.2 JYOUKI Pharmaceutical Co Glycerophosphorylcholine (GPC) Product Portfolio
7.6.3 JYOUKI Pharmaceutical Co Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.6.4 JYOUKI Pharmaceutical Co Main Business and Markets Served
7.6.5 JYOUKI Pharmaceutical Co Recent Developments/Updates
7.7 Wuxi Cima Science Co
7.7.1 Wuxi Cima Science Co Glycerophosphorylcholine (GPC) Company Information
7.7.2 Wuxi Cima Science Co Glycerophosphorylcholine (GPC) Product Portfolio
7.7.3 Wuxi Cima Science Co Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Wuxi Cima Science Co Main Business and Markets Served
7.7.5 Wuxi Cima Science Co Recent Developments/Updates
7.8 Changsha Jiaxi Biotechnology
7.8.1 Changsha Jiaxi Biotechnology Glycerophosphorylcholine (GPC) Company Information
7.8.2 Changsha Jiaxi Biotechnology Glycerophosphorylcholine (GPC) Product Portfolio
7.8.3 Changsha Jiaxi Biotechnology Glycerophosphorylcholine (GPC) Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Changsha Jiaxi Biotechnology Main Business and Markets Served
7.8.5 Changsha Jiaxi Biotechnology Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Glycerophosphorylcholine (GPC) Industry Chain Analysis
8.2 Glycerophosphorylcholine (GPC) Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Glycerophosphorylcholine (GPC) Production Mode & Process Analysis
8.4 Glycerophosphorylcholine (GPC) Sales and Marketing
8.4.1 Glycerophosphorylcholine (GPC) Sales Channels
8.4.2 Glycerophosphorylcholine (GPC) Distributors
8.5 Glycerophosphorylcholine (GPC) Customer Analysis
9 Glycerophosphorylcholine (GPC) Market Dynamics
9.1 Glycerophosphorylcholine (GPC) Industry Trends
9.2 Glycerophosphorylcholine (GPC) Market Drivers
9.3 Glycerophosphorylcholine (GPC) Market Challenges
9.4 Glycerophosphorylcholine (GPC) Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Glycerophosphorylcholine (GPC) market size was US$ 75.7 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 5.7% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 76
USD 4250.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market was valued at US$ 75.7 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 135
USD 2900.00
(Single User License)
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 75.7 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 103
USD 3950.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market size was US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 76
USD 4250.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market is projected to grow from US$ 72 million in 2024 to US$ 105 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 135
USD 4900.00
(Single User License)
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 105
USD 3950.00
(Single User License)
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Published Date: 2024-01-18
Pages: 106
USD 3950.00
(Single User License)
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Published Date: 2024-01-03
Pages: 91
USD 2900.00
(Single User License)
The global Glycerophosphorylcholine (GPC) market size was US$ 75.7 million in 2025 and is forecast to reach a readjusted size of US$ 111 million by 2032 with a CAGR of 5.7% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 76
The global Glycerophosphorylcholine (GPC) market was valued at US$ 75.7 million in 2025 and is anticipated to reach US$ 111 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 135
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 75.7 million in 2025 and is projected to reach US$ 111 million, growing at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-01-05
Pages: 103
The global Glycerophosphorylcholine (GPC) market size was US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 76
The global Glycerophosphorylcholine (GPC) market is projected to grow from US$ 72 million in 2024 to US$ 105 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 135
The global market for Glycerophosphorylcholine (GPC) was estimated to be worth US$ 72 million in 2024 and is forecast to a readjusted size of US$ 105 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 105
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Published: 2024-01-18
Pages: 106
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias. Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS). Industrially, alpha-GPC is produced by the chemical or enzymatic deacylation of phosphatidylcholine enriched soya phospholipids followed by chromatographic purification. Alpha-GPC may also be derived in small amounts from highly purified soy lecithin as well as from purified sunflower lecithin. The Glycerophosphorylcholine (GPC) market covers Liquid Glycerophosphorylcholine, Powder Glycerophosphorylcholine, etc. The typical players include Lipoid GmbH, Archimica SpA, Jiangsu Weiqida Pharmaceutical Co, Suzhou Fushilai Pharmaceutical, Foman Biopharma, JYOUKI Pharmaceutical Co, Wuxi Cima Science Co, Changsha Jiaxi Biotechnology, etc.
Published: 2024-01-03
Pages: 91
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now